Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
-1.54%
3-Month Return
+15.28%
12-Month Return
+50.77%
Volatility Score
1.9
RSI
55.3
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $220B | +53.88% | +16.21% | -8.52% | 2.6 | Neutral | Up |
| GILD | Gilead Sciences | $186B | +38.20% | +20.27% | +2.58% | 2.3 | Up | Up |
| VRTX | Vertex Pharma | $132B | +36.80% | +9.93% | -4.60% | 2.2 | Neutral | Up |
| REGN | Regeneron Pharma | $82B | +44.03% | +27.83% | -3.92% | 2.5 | Neutral | Up |
| MRNA | MODERNA | $78B | +691.63% | +222.44% | +40.27% | 6.0 | Up | Up |
| ARGX | arGEN-X SpADR | $60B | +35.32% | +12.87% | -4.84% | 2.6 | Neutral | Up |
| NTRA | Natera | $59B | +149.78% | +57.25% | +24.74% | 3.0 | Up | Up |
| RVMD | REVOLUTION MEDIC | $43B | +370.15% | +17.72% | -5.54% | 4.1 | Neutral | Up |
| ILMN | Illumina | $41B | +197.10% | +56.43% | +22.70% | 4.0 | Up | Up |
| ONC | BeOne Medi Sp ADR | $41B | +9.51% | +29.90% | -3.23% | 2.4 | Up | Up |
| BIIB | Biogen | $33B | +66.85% | +13.41% | +3.78% | 2.5 | Up | Up |
| ALNY | Alnylam Pharma | $33B | -44.48% | -15.12% | +5.75% | 4.1 | Neutral | Down |
| INSM | Insmed | $27B | -10.35% | +17.49% | -1.96% | 4.0 | Neutral | Down |
| ROIV | ROIVANT SCIENCES | $26B | +141.51% | +6.23% | -0.63% | 4.5 | Down | Up |
| INCY | Incyte | $25B | +52.39% | +14.73% | -2.77% | 2.6 | Neutral | Up |
| BNTX | BioNTech Sp ADR | $25B | +1.20% | +10.03% | -12.02% | 3.6 | Neutral | Neutral |
| GMAB | GENMAB SP ADR | $21B | +20.77% | +34.66% | +5.48% | 2.4 | Up | Up |
| UTHR | United Therapeut | $20B | +11.00% | -14.13% | -7.93% | 2.9 | Down | Down |
| MEDP | Medpace Holdings | $17B | +27.18% | +21.02% | +0.09% | 2.3 | Up | Up |
| ASND | Ascendis Pharma Br | $15B | +21.59% | -3.07% | -8.43% | 4.4 | Down | Down |
| TEM | TEMPUS AI-A | $15B | +6.35% | +58.34% | +24.29% | 5.7 | Up | Up |
| EXEL | Exelixis | $14B | +49.78% | +9.61% | +6.23% | 2.8 | Up | Up |
| NBIX | Neurocrine Biosc | $14B | -1.38% | -16.33% | -9.21% | 3.0 | Down | Down |
| CRL | Charles Riv Lab | $14B | +102.27% | +45.69% | -1.39% | 3.3 | Up | Up |
| HALO | Halozyme Therape | $13B | +55.77% | +61.94% | +6.06% | 2.6 | Up | Up |
| SMMT | SUMMIT THERAP | $13B | -19.15% | +14.95% | +28.67% | 6.2 | Up | Down |
| BBIO | BRIDGEBIO PHARMA | $13B | +35.27% | -4.44% | -18.24% | 3.9 | Down | Down |
| TWST | TWIST BIOSCIENCE | $12B | +587.96% | +101.46% | +30.70% | 5.7 | Up | Up |
| BMRN | Biomarin Pharm | $12B | +16.59% | +7.01% | -5.72% | 2.6 | Down | Up |
| MDGL | Madrigal Pharmct | $12B | +21.33% | +0.68% | +0.24% | 3.4 | Down | Neutral |
| TECH | Bio-Techne | $11B | +44.57% | +23.40% | +0.25% | 0.2 | Neutral | Up |
| TXG | 10X GENOMICS-A | $11B | +603.85% | +143.09% | +31.83% | 5.5 | Up | Up |
| RGEN | Repligen | $11B | +56.68% | +37.75% | +4.97% | 3.5 | Up | Up |
| AXSM | Axsome Therapeut | $10B | +68.98% | -17.61% | -4.56% | 4.0 | Down | Down |
| KRYS | KRYSTAL BIOTECH | $10B | +114.06% | -0.77% | +0.95% | 3.2 | Neutral | Up |
| BRKR | Bruker | $9.8B | +108.81% | +9.60% | +12.41% | 4.4 | Up | Up |
| KYMR | KYMERA THERAP | $9.6B | +115.52% | +15.96% | -4.33% | 4.3 | Neutral | Up |
| ARWR | Arrowhead Phrmct | $9.3B | +108.69% | -17.22% | -23.82% | 6.1 | Down | Down |
| IBRX | IMMUNITYBIO | $9.2B | +251.22% | +10.77% | +13.98% | 5.8 | Up | Up |
| CYTK | Cytokinetics | $9.1B | +37.28% | -19.14% | -14.83% | 4.0 | Down | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |